Home » Newsletters » BioWorld Science

BioWorld Science

July 10, 2015

View Archived Issues

Hepatocyte-tageted insulin gene transfer induces tolerance and protects against T1D

Sacituzumab govitecan shows acceptable safety profile

Sanofi extends collaboration with Medicines for Malaria Venture

Immunovaccine and PharmAthene to develop anthrax vaccine formulated in DepoVax

Novartis develops LTA4H inhibitors

Purdue Pharma presents Na1.7 channel blockers

Orion designs BET inhibitors

Sunshine Lake Pharma reports 5-HT reuptake inhibitors/5-HT1A receptor agonists

Vaccine candidate LT-69 confers long-term protection against M. tuberculosis infection in mice

Idarucizumab rapidly and completely reverses anticoagulant effects of dabigatran in clinical trial

Coretherapix's allogeneic human cardiac stem cells infusion enters phase I/II clinical trial

Nintedanib shows potent antifibrotic effects in preclinical models of SSc

Novel BTK inhibitor shows potential for the treatment of RA

FDA clears phase IIa study of AR-301 in acute pneumonia to expand into U.S.

Anika Therapeutics reports data from follow-up study of Cingal

Seattle Genetics begins Adcetris trial in systemic lupus erythematosus

Sorrento and NantBioScience to develop small molecule therapies against cancer

FDA grants fast track designation to Toca-511 & Toca-FC for recurrent glioma

Ultragenyx reports Fast Track designation and 40-week treatment data of KRN-23 in pedriatic XLH

Lancaster University researchers plan trial of liragutide in ALS

NIH grant supports Califia Bio's development of CLFB-1134 to treat cognitive deficits in MS

FDA approves first COPD biomarker

OWL to develop companion diagnostic for Galmed's Aramchol

ORIG3N to generate cells for research into Sturge-Weber syndrome

Aquinox's AQX-1125 fails to show benefit in phase II COPD trial

Globavir licenses BC-001 to Sorrento Therapeutics

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...